To support the use of NT-proBNP to better detect heart failure in patients with type 2 diabetes

被引：0
|
作者：
Francesco Lapi
Ettore Marconi
Gerardo Medea
Damiano Parretti
Carlo Piccinni
Aldo Pietro Maggioni
Claudio Cricelli
机构：
[1] Health Search,
[2] Italian College of General Practitioners and Primary Care,undefined
[3] Italian College of General Practitioners and Primary Care,undefined
[4] Fondazione ReS (Ricerca e Salute—Health and Research Foundation),undefined
[5] ANMCO Research Center Heart Care Foundation,undefined
来源：
Endocrine | 2023年 / 82卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：42 / 46
页数：4
相关论文
共 50 条
  • [21] NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?
    Cavender, Matthew A.
    Scirica, Benjamin M.
    DIABETES CARE, 2020, 43 (12) : 2904 - 2905
  • [22] NT-proBNP: An independent predictor of heart failure
    Bibbins-Domingo, K
    Ali, S
    Wu, AH
    Whooley, MA
    CIRCULATION, 2006, 113 (08) : E333 - E333
  • [23] Sequential Evaluation of NT-proBNP in Heart Failure
    Armstrong, Paul W.
    Zheng, Yinggan
    Troughton, Richard W.
    Lund, Lars H.
    Zhang, Jian
    Lam, Carolyn S. P.
    Westerhout, Cynthia M.
    Blaustein, Robert O.
    Butler, Javed
    Hernandez, Adrian F.
    Roessig, Lothar
    O'Connor, Christopher M.
    Voors, Adrian A.
    Ezekowitz, Justin A.
    JACC-HEART FAILURE, 2022, 10 (09) : 677 - 688
  • [24] NT-PROBNP GUIDED HEART FAILURE THERAPY
    Januzzi, James L., Jr.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S174 - S174
  • [25] NT-proBNP to Exclude cardiovascular Complications in Patients with Type 2 Diabetes mellitus
    Resl, Michael
    Neuhold, Stephanie
    Prager, Rudolf
    Brath, Helmut
    Francesconi, Claudia
    Luger, Anton
    Pacher, Richard
    Huelsmann, Martin
    Clodi, Martin
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S9 - S9
  • [26] NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
    Bolivar Malachias, Marcus Vinicius
    Wijkman, Magnus Olof
    Bertoluci, Marcello Casaccia
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [27] NT-proBNP to Exclude cardiovascular Complications in Patients with Diabetes mellitus Type 2
    Resl, M.
    Huelsmann, M.
    Pacher, R.
    Luger, A.
    Clodi, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (17-18) : 559 - 559
  • [28] NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes
    Marcus Vinicius Bolivar Malachias
    Magnus Olof Wijkman
    Marcello Casaccia Bertoluci
    Diabetology & Metabolic Syndrome, 14
  • [29] NT-proBNP and mortality in type 1 diabetes
    Grimmeshave, L.
    Pedersen-Bjergaard, U.
    Kistorp, C.
    Faber, J.
    DIABETOLOGIA, 2006, 49 : 31 - 31
  • [30] NT-proBNP and mortality in type 1 diabetes
    Grimmeshave, Lise
    Pedersen-Bjergaard, Ulrik
    Kistorp, Caroline
    Faber, Jens
    Thorsteinsson, Birger
    DIABETES, 2006, 55 : A156 - A157
12345